Pig dorsum model for examining impaired wound healing at the skin-implant interface of percutaneous devices

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 9, 2013, Pages 2181-2193

  Holt, Brian Mueller ^a,b   Betz, Daniel Holod ^a   Ford, Taylor Ann ^a   Beck, James Peter ^a,b   Bloebaum, Roy Drake ^a,b   Jeyapalina, Sujee ^a,b  

^a Salt Lake City Hlth Care S   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICES; HEALTH CARE PROVIDERS; IMMUNOHISTOCHEMICAL ANALYSIS; IMMUNOHISTOCHEMISTRY; PERCUTANEOUS DEVICES; QUANTITATIVE IMAGE ANALYSIS; QUANTITATIVE MEASURES; TRANSEPIDERMAL WATER LOSS;

MAMMALS; PROSTHETICS; TISSUE;

IMPLANTS (SURGICAL);

CD45 ANTIGEN; COLLAGEN TYPE 4; CYTOKERATIN 6; PROCOLLAGEN; PROCOLLAGEN C PROTEINASE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORRELATION ANALYSIS; EXPLANT; HISTOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MEDICAL DEVICE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN MANIFESTATION; SKIN WATER LOSS; SWINE; VALIDATION PROCESS; WOUND HEALING; WOUND HEALING IMPAIRMENT;

OVIS ARIES; SUIDAE;

ANIMALS; BODY WATER; MODELS, BIOLOGICAL; PROSTHESES AND IMPLANTS; SWINE; SWINE, MINIATURE; WOUND HEALING;

EID: 84884285563     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4975-5     Document Type: Article

References (59)

1. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001;33:1567-72.
2. Scott RD. The Direct Medical Costs of Healthcare-Associated Infections in US Hospitals and the Benefits of Prevention, 2009. Atlanta: Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Coordinating Center for Infectious Diseases, Center for Disease Control and Prevention; 2009.
3. Crnich CJ, Drinka P. Medical device-associated infections in the long-term care setting. Infect Dis Clin North Am. 2012;26:143-64.
4. Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, Cardo DM. Estimating health care-associated infection and deaths in US hospitals, 2002. Public Health Rep. 2007;122:160-6.
5. Trautner BW, Darouiche RO. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med. 2004;164:842-50.
6. McCann MT, Gilmore BF, Gorman SP. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J Pharm Pharmacol. 2008;60:1551-71.
7. Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol Med Microbiol. 2010;59:227-38.
8. Gerritsen M, Paquay YG, Jansen JA. Evaluation of the tissue reaction to a percutaneous access device using titanium fibre mesh anchorage in goats. J Mater Sci Mater Med. 1998;9:523-8.
9. Jansen JA, Paquay YG, van der Waerden JP. Tissue reaction to soft-tissue anchored percutaneous implants in rabbits. J Biomed Mater Res. 1994;28:1047-54.
10. Loesberg WA, te Riet J, van Delft FC, Schon P, Figdor CG, Speller S, van Loon JJ, Walboomers XF, Jansen JA. The threshold at which substrate nanogroove dimensions may influence fibroblast alignment and adhesion. Biomaterials. 2007;28:3944-51.
11. Paquay YC, de Ruijter JE, van der Waerden JP, Jansen JA. Tissue reaction to Dacron velour and titanium fibre mesh used for anchorage of percutaneous devices. Biomaterials. 1996;17:1251-6.
12. Walboomers XF, Croes HJE, Ginsel LA, Jansen JA. Contact guidance of rat fibroblasts on various implant materials. J Biomed Mater Res. 1999;47:204-12.
13. Pendegrass CJ, Goodship AE, Blunn GW. Development of a soft tissue seal around bone-anchored transcutaneous amputation prostheses. Biomaterials. 2006;27:4183-91.
14. Pendegrass CJ, Goodship AE, Price JS, Blunn GW. Nature's answer to breaching the skin barrier: an innovative development for amputees. J Anat. 2006;209:59-67.
15. Owings M, Kozak L. Ambulatory and inpatient procedures in the United States, 1996. Vital Health Stat 13. 1998;139:1-119.
16. Lyon CC, Kulkami J, Zimerson E, Van Ross E, Beck MH. Skin disorders in amputees. J Am Acad Dermatol. 2000;42:501-7.
17. Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008;89:422-9.
18. Meulenbelt HE, Geertzen JH, Jonkman MF, Dijkstra PU. Determinants of skin problems of the stump in lower-limb amputees. Arch Phys Med Rehabil. 2009;90:74-81.
19. Aschoff HH, Kennon RE, Keggi JM, Rubin LE. Transcutaneous, distal femoral, intramedullary attachment for above-the-knee prostheses: an endo-exo device. J Bone Joint Surg Am. 2010;92:180-6.
20. Hagberg K, Branemark R. One hundred patients treated with osseointegrated transfemoral amputation prostheses-rehabilitation perspective. J Rehabil Res Dev. 2009;46:331-44.
21. Hagberg K, Haggstrom E, Jonsson S, Rydevik B, Branemark R. Osseoperception and osseointegrated prosthetic limbs. Psychoprosthetics. London: Springer; 2008. p. 131-40.
22. Kang NV, Pendegrass C, Marks L, Blunn G. Osseocutaneous integration of an intraosseous transcutaneous amputation prosthesis implant used for reconstruction of a transhumeral amputee: case report. J Hand Surg Am. 2010;35:1130-4.
23. Sullivan J, Uden M, Robinson KP, Sooriakumaran S. Rehabilitation of the trans-femoral amputee with an osseointegrated prosthesis: the United Kingdom experience. Prosthet Orthot Int. 2003;27:114-20.
24. Hagberg K, Brânemark R, Gunterberg B, Rydevik B. Osseointegrated trans-femoral amputation prostheses: prospective results of general and condition-specific quality of life in 18 patients at 2-year follow-up. Prosthet Orthot Int. 2008;32:29-41.
25. Tillander J, Hagberg K, Hagberg L, Brânemark R. Osseointegrated titanium implants for limb prostheses attachments. Clin Orthop Relat Res. 2010;468:2781-8.
26. Mustoe TA, Cooter RD, Gold MH, Hobbs R, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler UE. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-71.
27. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835-70.
28. Profyris C, Tziotzios C, Do Vale I. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics part I. The molecular basis of scar formation. J Am Acad Dermatol. 2012;66:1-10.
29. Tziotzios C, Profyris C, Sterling J. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics part II. Strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol. 2012;66:13-24.
30. Murphy PS, Evans GRD. Advances in wound healing: a review of current wound healing products. Plast Surg Int. 2012;190436:1-8.
31. Eisenbud DE. Oxygen in wound healing - nutrient, antibiotic, signaling molecule, and therapeutic agent. Clin Plast Surg. 2012;39(3):293-310.
32. Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Babilas P. Oxygen in acute and chronic wound healing. Br J Dermatol. 2010;163:257-68.
33. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen. 2011;19(2):134-48.
34. Sen CK, Sashwati R. Redox signals in wound healing. Biochim Biophys Acta. 2008;1780(11):1348-61.
35. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005;15(11):599-607.
36. Mustoe TA, Gurjala A. The role of the epidermis and the mechanism of action of occlusive dressings in scarring. Wound Rep Regen. 2011;19:S16-21.
37. Perry EL, Beck JP, Williams DL, Bloebaum RD. Assessing peri-implant tissue infection prevention in a percutaneous model. J Biomed Mater Res B Appl Biomater. 2010;92:397-408.
38. Isackson D, McGill LD, Bachus KN. Percutaneous implants with porous titanium dermal barriers: an in vivo evaluation of infection risk. Med Eng Phys. 2011;33:418-26.
39. Jeyapalina S, Beck JP, Bachus KN, Williams DL, Bloebaum RD. Efficacy of a porous-structured titanium subdermal barrier for preventing infection in percutaneous osseointegrated prostheses. J Orthop Res. 2012;30(8):1304-11.
40. Middelkoop E, van den Bogaerdt AJ, Lamme EN, Hoekstra MJ, Brandsma K, Ulrich MMW. Porcine wound models for skin substitution and burn treatment. Biomaterials. 2004;25:1559-67.
41. Sullivan TP, Eaglstein WH, Davis SC, Mertz BA. The pig as a model for human wound healing. Wound Repair Regen. 2001;9:66-76.
42. Steinstraesser L, Vranckx JJ, Mohammadi-Tabrisi A, Jacobsen F, Mittler D, Lehnhardt M, Langer S, Kuhnen C, Gatermann S, Steinau HU, Eriksson E. A novel titanium wound chamber for the study of wound infections in pigs. Comp Med. 2006;56(4):279-85.
43. Wiechula R. The use of moist wound-healing dressings in the management of split-thickness skin graft donor sites: a systematic review. Int J Nurs Pract. 2003;9:S9-17.
44. Gallant-Behm CL, Mustoe TA. Occlusion regulates epidermal cytokine production and inhibits scar formation. Wound Repair Regen. 2010;18:235-44.
45. Holgers KM, Tjellström A, Bjursten LM, Erlandsson BE. Soft tissue reactions around percutaneous implants: a clinical study of soft tissue conditions around skin-penetrating titanium implants for bone-anchored hearing aids. Am J Otol. 1988;9:56-9.
46. Chou TG, Petti CA, Szakacs J. Evaluating antimicrobials and implant materials for infection prevention around transcutaneous osseointegrated implants in a rabbit model. J Biomed Mater Res A. 2010;92:942-52.
47. Emmanual J, Hornbeck C, Bloebaum RD. A polymethyl methacrylate method for large specimens of mineralized bone with implants. Stain Technol. 1987;62:401-10.
48. Wong P, Coulombe PA. Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. J Cell Biol. 2003;163(2):327-37.
49. Holt BM, Bachus KN, Beck JP, Bloebaum RD, Jeyapalina S. Immediate post-implantation skin immobilization decreases skin regression around percutaneous osseointegrated prosthetic (POP) implant systems. J Biomed Mater Res A. 2012 (in press).
50. Wong P, Coulombe PA. Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. J Cell Biol. 2003;163:327-37.
51. Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen FB, Beelen RH. Macrophages in skin injury and repair. Immunobiology. 2011;216:753-62.
52. Abreu-Velez AM, Howard MS. Collagen IV in normal skin and in pathological processes. N Am J Med Sci. 2012;4:1-8.
53. Sarrazy V, Billet F, Micallef L, Coulomb B, Desmoulière A. Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen. 2011;19:S10-5.
54. Ogawa R. Mechanobiology of scarring. Wound Repair Regen. 2011;19:S2-9.
55. Widgerow AD. Cellular/extracellular matrix cross-talk in scar evolution and control. Wound Repair Regen. 2011;19:117-33.
56. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001;166:7556-62.
57. Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hematol. 2010;38:548-56.
58. Grieb G, Steffens G, Pallua N, Bernhagen J, Bucala R. Circulating fibrocytes - biology and mechanisms in wound healing and scar formation. Int Rev Cell Mol Biol. 2011;291:1-19.
59. Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol. 2011;6:427-35.